Medicare Enrolled
Dr. Bhupinder Chatrath, MD
Hematology & Oncology · Hanford, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chatrath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chatrath?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chatrath
Dr. Bhupinder Chatrath is a hematology & oncology specialist in Hanford, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chatrath performed 77,962 Medicare services across 2,730 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chatrath received a total of $25,776 from 93 pharmaceutical and/or device companies across 1449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chatrath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in CA
$25,776 industry payments
Medicare Practice Summary
Medicare Utilization ↗77,962
Medicare services
Top 10% in CA for hematology & oncology
2,730
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,898 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
23,160 | $0 | $1 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 14,680 | $0 | $6 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
13,500 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 5,221 | $19 | $38 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,950 | $0 | $6 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,880 | $6 | $22 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,708 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,714 | $97 | $165 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,487 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,390 | $1 | $34 |
| Injection, granisetron hydrochloride, 100 mcg | 1,370 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
965 | $8 | $11 |
| Injection, leucovorin calcium, per 50 mg | 573 | $3 | $11 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
449 | $111 | $242 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
434 | $12 | $38 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
377 | $13 | $35 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
329 | $2 | $8 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
198 | $24 | $55 |
| New patient office visit, complex (60-74 min) | 162 | $173 | $313 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
150 | $23 | $77 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
137 | $1 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $74 | $115 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
105 | $1 | $7 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
100 | $1 | $5 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
92 | $11 | $26 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
85 | $21 | $43 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
84 | $54 | $117 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
77 | $54 | $110 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
77 | $2 | $5 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
62 | $1 | $2 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
59 | $80 | $168 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $28 | $86 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 47 | $330 | $761 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
44 | $81 | $158 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
32 | $26 | $69 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
30 | $63 | $123 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
27 | $144 | $293 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
21 | $32 | $85 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $141 | $305 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.6% high complexity
75.2% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,776
Total received (2018-2024)
Avg $3,682/year across 7 years
Top 17% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,449
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,328 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,448 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,435
2023
$5,594
2022
$4,389
2021
$3,349
2020
$2,404
2019
$4,111
2018
$3,493
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$256
Astellas Pharma US Inc
$252
Janssen Biotech, Inc.
$220
AstraZeneca Pharmaceuticals LP
$188
PFIZER INC.
$153
GlaxoSmithKline, LLC.
$146
Merck Sharp & Dohme LLC
$141
Celgene Corporation
$101
Ipsen Biopharmaceuticals, Inc
$100
Daiichi Sankyo Inc.
$97
Genentech USA, Inc.
$60
Coherus Biosciences Inc.
$58
GENZYME CORPORATION
$56
Apellis Pharmaceuticals, Inc.
$56
Eisai Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$46
Incyte Corporation
$36
PharmaEssentia USA Corporation
$32
JAZZ PHARMACEUTICALS INC.
$31
E.R. Squibb & Sons, L.L.C.
$31
ImmunoGen, Inc.
$29
ABBVIE INC.
$29
Medtronic, Inc.
$25
TAIHO ONCOLOGY, INC.
$25
Exelixis Inc.
$25
SOBI, INC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Gilead Sciences, Inc.
$21
Azurity Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$20
Regeneron Healthcare Solutions, Inc.
$19
SpringWorks Therapeutics, Inc.
$18
Blueprint Medicines Corporation
$18
Deciphera Pharmaceuticals Inc.
$16
EMD Serono, Inc.
$16
Top 3 companies account for 29.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,996
E.R. Squibb & Sons, L.L.C.
$1,771
Novartis Pharmaceuticals Corporation
$1,724
Janssen Biotech, Inc.
$1,536
Amgen Inc.
$1,439
PFIZER INC.
$1,003
Genentech USA, Inc.
$945
Exelixis Inc.
$933
Astellas Pharma US Inc
$888
GlaxoSmithKline, LLC.
$857
GENZYME CORPORATION
$764
Daiichi Sankyo Inc.
$745
Celgene Corporation
$696
Merck Sharp & Dohme Corporation
$626
Lilly USA, LLC
$622
Incyte Corporation
$546
Takeda Pharmaceuticals U.S.A., Inc.
$508
Seagen Inc.
$498
Merck Sharp & Dohme LLC
$441
Eisai Inc.
$412
Alexion Pharmaceuticals, Inc.
$345
EISAI INC.
$286
Stemline Therapeutics Inc.
$273
Bayer HealthCare Pharmaceuticals Inc.
$255
MorphoSys, US Inc.
$252
Pharmacyclics LLC, An AbbVie Company
$234
Seattle Genetics, Inc.
$228
SOBI, INC
$228
Ipsen Biopharmaceuticals, Inc
$211
Puma Biotechnology, Inc.
$210
ABBVIE INC.
$201
Coherus Biosciences Inc.
$195
TESARO, Inc.
$185
Apellis Pharmaceuticals, Inc.
$183
EMD Serono, Inc.
$171
ARRAY BIOPHARMA INC
$170
TerSera Therapeutics LLC
$164
AbbVie Inc.
$156
Regeneron Healthcare Solutions, Inc.
$151
SANOFI-AVENTIS U.S. LLC
$147
Gilead Sciences, Inc.
$146
Kite Pharma, Inc.
$143
Karyopharm Therapeutics Inc.
$142
AVEO Pharmaceuticals, Inc.
$129
BeiGene USA, Inc.
$126
Sobi, Inc
$124
Bayer Healthcare Pharmaceuticals Inc.
$112
Dova Pharmaceuticals
$105
TAIHO ONCOLOGY, INC.
$93
Octapharma USA, Inc.
$86
Blueprint Medicines Corporation
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Rigel Pharmaceuticals, Inc.
$60
Deciphera Pharmaceuticals Inc.
$58
Pharmacyclics LLC, an AbbVie Company
$57
MEDIVATION FIELD SOLUTIONS LLC
$53
Teva Pharmaceuticals USA, Inc.
$53
Kyowa Kirin, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$51
Mirati Therapeutics, Inc.
$50
Spectrum Pharmaceuticals Inc.
$44
Myriad Genetic Laboratories, Inc.
$44
AMAG Pharmaceuticals, Inc.
$43
Dendreon Pharmaceuticals LLC
$39
CTI BioPharma Corp.
$35
MAYNE PHARMA INC.
$34
PharmaEssentia USA Corporation
$32
Janssen Pharmaceuticals, Inc
$30
ImmunoGen, Inc.
$29
Acrotech Biopharma LLC
$27
Sirtex Medical Inc
$27
Medtronic, Inc.
$25
AbbVie, Inc.
$25
Clovis Oncology, Inc.
$24
Azurity Pharmaceuticals, Inc.
$21
Pharmacosmos Therapeutics Inc.
$21
Blue Earth Diagnostics Limited
$21
Acerta Pharma LLC
$21
Fresenius Kabi USA, LLC
$20
R-Pharm US LLC
$19
ADC Therapeutics America, Inc.
$19
Myovant Sciences Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$18
SpringWorks Therapeutics, Inc.
$18
EUSA Pharma (US) LLC
$18
RECORDATI_RARE_DISEASES_INC.
$18
Aveo Pharmaceuticals, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Taiho Oncology, Inc.
$16
Secura Bio, Inc.
$14
BTG International, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$13
Epizyme, Inc.,
$12
Top 3 companies account for 21.3% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAPLAS · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stimufend · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TRIPTODUR · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VORAXAZE · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · WILATE · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
3
Per 100K population
2.0
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chatrath is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chatrath experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Chatrath performed 23,160 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chatrath receive payments from pharmaceutical companies?
Yes. Dr. Chatrath received a total of $25,776 from 93 companies across 1,449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chatrath's costs compare to other hematology & oncology specialists in Hanford?
Dr. Chatrath's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chatrath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Hanford
Browse hematology & oncology specialists in Hanford ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology